Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Not Likely To Hold Its Peace At Merck/Schering Altar

Executive Summary

Merck and Schering-Plough are talking up the future - the commercial, pipeline and cost savings advantages of a proposed $41.1 billion merger - like newlyweds who have already tied the knot, danced the first dance and cut the cake. But there's an uninvited guest at the affair, Johnson & Johnson, a third-party with bargaining power that could step in to thwart Merck and Schering's happily ever after
Advertisement

Related Content

Merck And J&J Settle Remicade Dispute By Redrawing The Map
Merck And J&J Settle Remicade Dispute By Redrawing The Map
J&J vs. Merck: What Might A Remicade Settlement Look Like?
Merck Financials Remain On Track, Despite Generic Cozaar, Health Reform
Merck Financials Remain On Track, Despite Generic Cozaar, Health Reform
Merck Financial Targets Remain On Track, Despite Generic Cozaar, Health Care Reform
Schering/J&J's Simponi Gets Positive EU Nod For Approval; J&J Seeks Full Rights To Drug
J&J To Seek Remicade Rights Amid Pending Schering-Plough/Merck Merger
J&J “Actively Engaged” Lobbying Against Obama Corporate Tax Provision
Merck/Schering: The Next Wave Of Consolidation

Topics

Advertisement
UsernamePublicRestriction

Register

PS050813

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel